iShares Nasdaq Biotechnology Index Fund (NASDAQ: IBB) and Compass Diversified Holdings (NYSE:CODI) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation.

Profitability

This table compares iShares Nasdaq Biotechnology Index Fund and Compass Diversified Holdings’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
iShares Nasdaq Biotechnology Index Fund N/A N/A N/A
Compass Diversified Holdings 2.20% 6.42% 3.06%

Dividends

iShares Nasdaq Biotechnology Index Fund pays an annual dividend of $0.69 per share and has a dividend yield of 0.2%. Compass Diversified Holdings pays an annual dividend of $1.44 per share and has a dividend yield of 8.2%. Compass Diversified Holdings pays out -276.9% of its earnings in the form of a dividend.

Risk & Volatility

iShares Nasdaq Biotechnology Index Fund has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500. Comparatively, Compass Diversified Holdings has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500.

Valuation & Earnings

This table compares iShares Nasdaq Biotechnology Index Fund and Compass Diversified Holdings’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
iShares Nasdaq Biotechnology Index Fund N/A N/A N/A N/A N/A
Compass Diversified Holdings $1.17 billion 0.90 $199.58 million ($0.52) -33.85

Compass Diversified Holdings has higher revenue and earnings than iShares Nasdaq Biotechnology Index Fund.

Insider and Institutional Ownership

55.7% of iShares Nasdaq Biotechnology Index Fund shares are owned by institutional investors. Comparatively, 33.2% of Compass Diversified Holdings shares are owned by institutional investors. 2.4% of Compass Diversified Holdings shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for iShares Nasdaq Biotechnology Index Fund and Compass Diversified Holdings, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iShares Nasdaq Biotechnology Index Fund 0 0 1 0 3.00
Compass Diversified Holdings 0 0 2 0 3.00

Compass Diversified Holdings has a consensus target price of $19.50, suggesting a potential upside of 10.80%. Given Compass Diversified Holdings’ higher possible upside, analysts plainly believe Compass Diversified Holdings is more favorable than iShares Nasdaq Biotechnology Index Fund.

Summary

Compass Diversified Holdings beats iShares Nasdaq Biotechnology Index Fund on 9 of the 11 factors compared between the two stocks.

iShares Nasdaq Biotechnology Index Fund Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Compass Diversified Holdings Company Profile

Compass Diversified Holdings (the Trust) and Compass Group Diversified Holdings, LLC, (the Company), acquires and manages small and middle-market businesses. The Company operates through segments include Acquisition Corp. (5.11 Tactical), The Ergo Baby Carrier, Inc. (Ergobaby), Liberty Safe and Security Products, Inc. (Liberty), Fresh Hemp Foods Ltd. (Manitoba Harvest), Compass AC Holdings, Inc. (ACI), AMT Acquisition Corporation (Arnold), Clean Earth Holdings, Inc. (Clean Earth), and Sterno Products, LLC (Sterno) segments. The Company categorizes the businesses into separate groups of businesses, such as branded consumer businesses and niche industrial businesses. The Company also owns a non-controlling interest in Fox Factory Holding Corp. (FOX). Compass Group Management LLC, (CGM or the Manager), manages the day to day operations of the Company and oversees the management and operations of its businesses pursuant to a management services agreement (MSA).

Receive News & Ratings for iShares Nasdaq Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.